Inhibitory activity of aqueous extracts was analyzed following a method by Hayakari et al. [22] https://dx.doi.org/10.17504/protocols.io.tb4eiqw. Hippuryl-L-histidyl-L-leucine (HHL) (Sigma) was hydrolyzed by ACE to yield hippuric acid and histidyl-leucine. This method relies on the colorimetric reaction of hippuric acid with 2, 4, 6-trichloro-s-triazine (TT) (Sigma). The tests were performed in triplicate and antihypertensive activity was quantified by a regression analysis of ACE inhibitory activity (%) versus phenolic compounds concentration in aqueous extract and defined as an IC50 value, that is, the concentration of phenolic compounds required to produce 50% ACE inhibition under the conditions described. For angiotensin-converting enzyme inhibitory assay, lisinopril (antihypertensive drug) was used as control.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.